Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes | Fibrogenesis & Tissue Repair | Full Text
Idiopathic Pulmonary Fibrosis | NEJM
IJMS | Free Full-Text | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs | HTML
IJMS | Free Full-Text | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs | HTML
Unifying mechanism for different fibrotic diseases | PNAS
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into | JIR
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis | EMBO Molecular Medicine
Frontiers | The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
Administration of aloperine attenuated lung fibrosis after BLM... | Download Scientific Diagram
Idiopathic pulmonary fibrosis: Are any of the morphological-molecular markers useful in clinical management? | Semantic Scholar
Fibroblasts and their responses to chronic injury in pulmonary fibrosis - ScienceDirect
Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation
Interstitial Lung Disease | ARUP Laboratories
![Differential Lysotracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis[v1] | Preprints](https://www.preprints.org/img/dyn_abstract_figures/2021/11/1272817178e65d48c7849464c391563d/preprints-52023-graphical.v1(1).jpg "Differential Lysotracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis[v1] | Preprints")
Differential Lysotracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis[v1] | Preprints
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis | EMBO Molecular Medicine
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program | Science Advances
Club cell-specific role of programmed cell death 5 in pulmonary fibrosis | Nature Communications
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines | European Respiratory Society
The potential indicators for pulmonary fibrosis in survivors of severe COVID-19 - Journal of Infection
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis | Nature Communications
Frontiers | Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems - ScienceDirect
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis | SpringerLink
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into | JIR
Frontiers | Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography
